ACE and liver dysplastic nodule: Importantly, leptin therapy, but not ACE inhibition, restored the mean number of podocytes in each glomerulus, implying that therapies other than renin-angiotensin system blockade are likely to be required to promote nephron regeneration in patients with DN.